Disc Medicine
IRON
Disc Medicine (IRON) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Wells Fargo | Maintained | Overweight | $86.00 from $79.00 | Sep 16, 2026 |
| Wedbush | Maintained | Outperform | $100.00 | Sep 10, 2026 |
| Wedbush | Maintained | Outperform | $100.00 from $88.00 | Sep 2, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $120.00 from $118.00 | Aug 6, 2026 |
| Morgan Stanley | Maintained | Overweight | $85.00 from $80.00 | Jun 16, 2026 |
| Wedbush | Maintained | Outperform | $88.00 | Jun 10, 2026 |
| Morgan Stanley | Maintained | Overweight | $80.00 from $75.00 | May 14, 2026 |
| Wells Fargo | Maintained | Overweight | $79.00 from $78.00 | Mar 2, 2026 |
| Truist Securities | Maintained | Buy | $83.00 from $114.00 | Feb 27, 2026 |
| Wells Fargo | Maintained | Overweight | $78.00 from $109.00 | Feb 17, 2026 |
| Wedbush | Maintained | Outperform | $88.00 from $110.00 | Feb 17, 2026 |
| BMO Capital | Maintained | Outperform | $100.00 from $120.00 | Feb 17, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $125.00 from $153.00 | Feb 17, 2026 |
| Stifel | Maintained | Buy | $110.00 from $125.00 | Feb 17, 2026 |
| Wells Fargo | Maintained | Overweight | $109.00 from $91.00 | Dec 16, 2025 |
| Truist Securities | Maintained | Buy | $114.00 from $86.00 | Nov 10, 2025 |
| Stifel | Maintained | Buy | $125.00 | Nov 3, 2025 |
| Morgan Stanley | Maintained | Overweight | $115.00 from $90.00 | Oct 30, 2025 |
| Wedbush | Maintained | Outperform | $110.00 from $90.00 | Oct 17, 2025 |
| Cantor Fitzgerald | Maintained | Overweight | $153.00 from $132.00 | Oct 17, 2025 |
Frequently asked questions
What is the latest analyst rating on IRON?
On Sep 16, 2026, Wells Fargo maintained Disc Medicine at Overweight with a price target of $86.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.